Quidel | QDEL - Net Income

Stock Price
10.42
Daily Change
0.10 0.97%
Monthly
-19.16%
Yearly
-68.01%
Q2 Forecast
10.11

Quidel reported $-91.8M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
Agilent USD 305M 129M Dec/2025
Avanos Medical USD 5.1M 6.4M Mar/2026
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Bruker USD 3.5M 22.5M Mar/2026
Cerus USD -20.92M 17.98M Dec/2024
Charles River Laboratories USD -14.84M 261.71M Mar/2026
Danaher USD 1.03B 168M Mar/2026
Haemonetics USD 44.74M 6.06M Dec/2025
Illumina USD 134M 200M Mar/2026
IQVIA Holdings USD 274M 240M Mar/2026
Merit Medical Systems USD 41M 2.99M Mar/2026
Mettler Toledo International USD 169.45M 116.31M Mar/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
Neogen USD -17M 1.08M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Quidel USD -91.8M 38.9M Mar/2026
Revvity USD 40.72M 57.65M Mar/2026
STAAR Surgical USD 5.21M 23.52M Mar/2026
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Waters USD -72M 297.21M Mar/2026